サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451431

薬剤溶出ステント市場レポート：コーティング、薬剤、ステントプラットフォーム、世代、用途、エンドユーザー、地域別、2024-2032

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
薬剤溶出ステント市場レポート：コーティング、薬剤、ステントプラットフォーム、世代、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

薬剤溶出ステントの世界市場規模は、2023年に83億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに137億米ドルに達し、2024～2032年の成長率（CAGR）は5.51%になると予測しています。

薬剤溶出ステント（DES）は、末梢動脈または冠動脈で薬剤を徐放し、細胞増殖を阻止して健全な血液の流れを促進するために使用される冠動脈デバイスです。DESは金属ステント、ポリマーコーティング、抗再狭窄薬で構成されています。ステントには動脈を円滑に保ち、十分な血流を確保するための薬剤がコーティングされています。DESは心臓動脈の閉塞を治療し、プラークの蓄積や血栓を予防し、繰り返される血行再建術を減らすために広く使用されています。このステントは低侵襲性（MI）で、再狭窄率が低く、血管の治癒が促進され、二重抗血小板療法の必要性が減少します。

薬剤溶出ステントの市場動向：

慢性疾患を抱えやすい高齢者人口の増加は、市場の成長を促進する重要な要因の1つです。DESは、ステントが冠動脈バイパス手術などの侵襲的処置の必要性を減らすのに役立つため、動脈障害を発症するリスクの高い患者に広く利用されています。さらに、大衆の不健康な食事パターン、運動不足、座りがちな生活スタイルによる心血管疾患の有病率の増加が、市場の成長を後押ししています。さらに、生体吸収性ステントの発売など、さまざまな技術の進歩が市場の成長を後押ししています。これらのステントは体内で容易に溶解可能で、ステント血栓症の発症リスクを低減します。これに伴い、ポリマーを含まないコーティングを施したステントの普及が市場成長にプラスの影響を与えています。これらのステントは薬剤充填能力が高く、薬剤溶出速度が速いです。その他の要因としては、異常心リズム、心不全、心筋梗塞の発生率の上昇、大衆の間でのMI技術に対する需要の増加などが挙げられ、市場の成長を後押しすると予想されています。

本レポートで扱う主な質問

  • 2023年の薬剤溶出ステントの世界市場規模は？
  • 2024～2032年の世界の薬剤溶出ステント市場の予想成長率は？
  • 世界の薬剤溶出ステント市場を牽引する主要因は？
  • COVID-19が世界の薬剤溶出ステント市場に与えた影響は？
  • コーティング別世界の薬剤溶出ステント市場の内訳は？
  • ステントプラットフォーム別世界の薬剤溶出ステント市場の内訳は？
  • 薬剤溶出ステントの世界市場の用途別区分は？
  • エンドユーザー別薬剤溶出ステントの世界市場の内訳は？
  • 薬剤溶出ステントの世界市場における主要地域は？
  • 薬剤溶出ステントの世界市場における主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 薬剤溶出ステントの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コーティング別

  • ポリマーベースコーティング
    • 市場動向
    • 市場予測
  • ポリマーフリーコーティング
    • 市場動向
    • 市場予測

第7章 市場内訳：薬剤別

  • シロリムス
    • 市場動向
    • 市場予測
  • パクリタキセル
    • 市場動向
    • 市場予測
  • ゾタロリムス
    • 市場動向
    • 市場予測
  • エベロリムス
    • 市場動向
    • 市場予測
  • バイオリムス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：ステントプラットフォーム別

  • ステンレス
    • 市場動向
    • 市場予測
  • コバルトクロム
    • 市場動向
    • 市場予測
  • プラチナクロム
    • 市場動向
    • 市場予測
  • ニチノール
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：世代別

  • 第1世代
    • 市場動向
    • 市場予測
  • 第2世代
    • 市場動向
    • 市場予測
  • 第3世代
    • 市場動向
    • 市場予測
  • 第4世代
    • 市場動向
    • 市場予測

第10章 市場内訳：用途別

  • 冠動脈疾患
    • 市場動向
    • 市場予測
  • 末梢動脈疾患
    • 市場動向
    • 市場予測

第11章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第12章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第13章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第14章 バリューチェーン分析

第15章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第16章 価格分析

第17章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd.
    • Biotronik
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC（Cook Group Incorporated）
    • Lepu Medical Technology（Beijing）Co. Ltd.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Sino Medical Sciences Technology Inc.
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2023
  • Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2023
  • Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2023
  • Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2023
  • Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2023
  • Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
  • Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
  • Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2024-2032
  • Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2024-2032
  • Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2024-2032
  • Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2024-2032
  • Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
  • Table 10: Global: Drug-Eluting Stents Market: Key Players
目次
Product Code: SR112024A4815

The global drug-eluting stents market size reached US$ 8.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.51% during 2024-2032.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

Polymer Based Coating

Polymer Free Coating

Breakup by Drug:

Sirolimus

Paclitaxel

Zotarolimus

Everolimus

Biolimus

Others

Breakup by Stent Platform:

Stainless-steel

Cobalt-Chromium

Platinum-Chromium

Nitinol

Others

Breakup by Generation:

1st Generation

2nd Generation

3rd Generation

4th Generation

Breakup by Application:

Coronary Artery Disease

Peripheral Artery Disease

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global drug-eluting stents market in 2023?
  • 2. What is the expected growth rate of the global drug-eluting stents market during 2024-2032?
  • 3. What are the key factors driving the global drug-eluting stents market?
  • 4. What has been the impact of COVID-19 on the global drug-eluting stents market?
  • 5. What is the breakup of the global drug-eluting stents market based on the coating?
  • 6. What is the breakup of the global drug-eluting stents market based on the stent platform?
  • 7. What is the breakup of the global drug-eluting stents market based on the application?
  • 8. What is the breakup of the global drug-eluting stents market based on the end user?
  • 9. What are the key regions in the global drug-eluting stents market?
  • 10. Who are the key players/companies in the global drug-eluting stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug-Eluting Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Coating

  • 6.1 Polymer Based Coating
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polymer Free Coating
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug

  • 7.1 Sirolimus
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Paclitaxel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Zotarolimus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Everolimus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Biolimus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Stent Platform

  • 8.1 Stainless-steel
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cobalt-Chromium
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Platinum-Chromium
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nitinol
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Generation

  • 9.1 1st Generation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 2nd Generation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 3rd Generation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 4th Generation
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Coronary Artery Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Peripheral Artery Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 B. Braun Melsungen AG
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Biosensors International Group Ltd.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Biotronik
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 SWOT Analysis
    • 17.3.5 Boston Scientific Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Cardinal Health Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 Cook Medical LLC (Cook Group Incorporated)
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 SWOT Analysis
    • 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Medtronic plc
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials
      • 17.3.9.4 SWOT Analysis
    • 17.3.10 MicroPort Scientific Corporation
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
    • 17.3.11 Sino Medical Sciences Technology Inc.
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Corporation
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio
      • 17.3.12.3 Financials
      • 17.3.12.4 SWOT Analysis